BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Stock Omicron'. (Return)

MarketWatch MarketPulseJan 25, 2022
Pfizer and BioNTech launch study to evaluate omicron-based COVID-19 vaccine for adults 18 to 55 years old
Pfizer Inc. and German partner BioNTech SE said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. "While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognize the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future," said Kathrin U. Jansen, Ph.D., senior vice president and head of vaccine R&D at Pfizer. The study will enroll up to $1,420 participants for three cohorts; one will comprise people who received two doses of the current Pfizer/BioNTech COVID vaccine 90 to 180 days prior to enrollment, with that group to receive one or two doses of the omicron vaccine; one comprised of people who received three doses of the existing vaccine and will get one dose of the current one or omicron one; and a third group of "vaccine-naive" people, who will get three doses of the omicron vaccine. Pfizer shares were down 1.1% premarket, while BioNTEch was down 0.8%. BioNTech remain up 36.5% in the last 12 months, while the SPDR S&P Biotech ETF has fallen 41% and the S&P 500 has gained 14%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.


TRENDING TAGS
StockMarket Buy Earnings Street Wall
StocksBuy Market S&P Dow Growth
WallStreet Stock stocks day Journal
StreetWall Stock stocks day Journal
TaxIRS Season credit child Know
Marketstock Futures Stocks Dow know
yeartax last meeting return Will
ChinaIMF Growth cuts global forecast
TodayStock Stocks Shares Again Higher
billionbillionaire GM bid Year Michigan

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2022 CEOExpress Company LLC